PZPiotr Zaleski

Piotr Zaleski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Piotr Zaleski has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular dissection of the replication system of plasmid pIGRK encoding two in-frame Rep proteins with antagonistic functions

    by Paweł Wawrzyniak, Agnieszka Sobolewska-Ruta, Piotr Zaleski, Natalia Łukasiewicz, Paulina Kabaj, Piotr Kierył, Agata Gościk, Anna Bierczyńska-Krzysik, Piotr Baran, Anna Mazurkiewicz-Pisarek, et al.

    Background: Gene overlapping is a frequent phenomenon in microbial genomes. Excluding so-called “trivial overlapping”, there are significant implications of such genetic arrangements, including regulation of gene expression and modification of protein activity. It is also postulated that, besides gene duplication, the appearance of overlapping genes (OGs) is one of the most important factors promoting a genome’s novelty and evolution. OGs coding for in-frame proteins with different functions are a particularly interesting case. In this study we identified and characterized two in-frame proteins encoded by OGs on plasmid pIGRK fromKlebsiella pneumoniae, a representative of the newly distinguished pHW126 plasmid family.Results: A singlerepRlocus located within the replication system of plasmid pIGRK encodes, in the same frame, two functional polypeptides: a full-length RepR protein and a RepR’ protein (withN-terminal truncation) translated from an internal START codon. Both proteins form homodimers, and interact with diverse DNA regions within the plasmid replication origin andrepRpromoter operator. Interestingly, RepR and RepR’ have opposing functions – RepR is crucial for initiation of pIGRK replication, while RepR’ is a negative regulator of this process. Nevertheless, both proteins act cooperatively as negative transcriptional regulators of their own expression.Conclusions: Regulation of the initiation of pIGRK replication is a complex process in which a major role is played by two in-frame proteins with antagonistic functions. In-frame encoded Rep proteins are uncommon, having been described in only a few plasmids. This is the first description of such proteins in a plasmid of the pHW126 family.


  • Open Access

    Expression and purification of recombinant human insulin from E. coli 20 strain

    by Marcin Zieliński, Agnieszka Romanik-Chruścielewska, Diana Mikiewicz, Natalia Łukasiewicz, Iwona Sokołowska, Jarosław Antosik, Agnieszka Sobolewska-Ruta, Anna Bierczyńska-Krzysik, Piotr Zaleski, Andrzej Płucienniczak


  • Open Access

    Cell Banks Preparation In Biopharmaceuticals Production

    by Agnieszka Sobolewska-Ruta, Piotr Zaleski

    The fast development of the biopharmaceutical market is correlated with the growing number and availability of technologies for the production of so-called biodrugs. One of the main procedures for therapeutic protein production is based on bacterial expression systems. In order to maintain the constant quality and homogeneity of the initial inoculum, the cell bank must be created in full accordance with quality standards. The first step should be the establishment of a Master Cell Bank (MCB), which must be performed in a laboratory that meets high quality standards and according to well-described main procedures. The MCB should be initiated from a single well-characterised bacterial colony. A Working Cell Bank (WCB) is usually prepared as a second step from one or few vials deposited in the MCB. The WCB must be characterised for bacterial strain homology and be free of any biological cross contamination. This paper describes the main requirements and good practises for the preparation of a cell bank suitable for constant and reproducible production of biopharmaceuticals. 1. Introduction. 2. Prokaryotic expression system. 3. Cell banking system. 4. Cell banks characterization. 4.1. Conformation of identity (properties) of the bacterial strain. 4.2. Confirmation of the purity of the bacterial strain. 5. Summary


  • Open Access

    Plasmids – vectors for gene therapy

    by Piotr Zaleski, Paweł Wawrzyniak, Agnieszka Sobolewska, Grażyna Płucienniczak

    The first confirmed transfer of genetic material in human was performed in 1990. Ever since, gene therapy was considered to be one of the best promising treatments of genetic diseases. The sine qua non of successful gene therapy are efficient genetic vectors. Recently, the most frequently used vectors in clinical trials for genetic therapies are virus-based and plasmid-based. A range of features makes plasmids useful for gene therapy, however, they have also some characteristics which make it difficult to consider plasmids as ideal vectors. The main goal of this article is to address and describe these unfavourable factors. 1. Introduction. 2. Natural modification of DNA as an obstacle to the use of plasmids for gene therapy. 3. Plasmid DNA usage safety. 4. Plasmid DNA entry into eucaryotic cells. 5. Post-entry fate of plasmid DNA in eucaryotic cells. 6. pDNA-based gene therapies. 7. Alternative routes of development of pDNA-based gene therapies. 7.1. Baktofection. 7.2. Alternative Gene Therapy – AGT. 7.3. Hydrogels. 7.4. DNA minicircles. 7.5. DNA ministrings. 8. Summary 1. Wstęp. 2. Naturalna modyfikacja DNA jako przeszkoda w stosowaniu plazmidów w terapii genowej. 3. Bezpieczeństwo użycia plazmidowego DNA. 4. Wprowadzenie pDNA do komórek eukariotycznych. 5. Los plazmidowego DNA po wprowadzeniu do komórek eukariotycznych. 6. Terapie genowe bazujące na pDNA. 7. Inne kierunki rozwoju terapii genowych opartych na plazmidowym DNA. 7.1 Baktofekcja. 7.2. Alternatywna terapia genowa (Alternative Gene Therapy – AGT). 7.3. Hydrożele. 7.4. Minikoliste DNA. 7.5. Mininici DNA. 8. Podsumowanie


  • pIGWZ12 – A cryptic plasmid with a modular structure

    by Piotr Zaleski, Paweł Wawrzyniak, Agnieszka Sobolewska, Natalia Łukasiewicz, Piotr Baran, Katarzyna Romańczuk, Katarzyna Daniszewska, Piotr Kierył, Grażyna Płucienniczak, Andrzej Płucienniczak


  • Open Access

    Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination ofβ-Lactam Resistance Genes among the Enterobacteriaceae

    by Marcin Adamczuk, Piotr Zaleski, Lukasz Dziewit, Renata Wolinowska, Marta Nieckarz, Pawel Wawrzyniak, Piotr Kieryl, Andrzej Plucienniczak, Dariusz Bartosik

    Antibiotic resistance determinants are frequently associated with plasmids and other mobile genetic elements, which simplifies their horizontal transmission. Several groups of plasmids (including replicons of the IncL/M incompatibility group) were found to play an important role in the dissemination of resistance genes encodingβ-lactamases. The IncL/M plasmids are large, broad host range, and self-transmissible replicons. We have identified and characterized two novel members of this group: pARM26 (isolated from bacteria inhabiting activated sludge from a wastewater treatment plant) and pIGT15 (originating from a clinical strain ofEscherichia coli). This instigated a detailed comparative analysis of all available sequences of IncL/M plasmids encodingβ-lactamases. The core genome of these plasmids is comprised of 20 genes with conserved synteny. Phylogenetic analyses of these core genes allowed clustering of the plasmids into four separate groups, which reflect their antibiotic resistance profiles. Examination of the biogeography of the IncL/M plasmids revealed that they are most frequently found in bacteria of the family Enterobacteriaceae originating from the Mediterranean region and Western Europe and that they are able to persist in various ecological niches even in the absence of direct antibiotic selection pressure.


  • New cloning and expression vector derived from Escherichia coli plasmid pIGWZ12; A potential vector for a two-plasmid expression system

    by Piotr Zaleski, Pawel Wawrzyniak, Agnieszka Sobolewska, Diana Mikiewicz, Anna Wojtowicz-Krawiec, Luiza Chojnacka-Puchta, Marcin Zielinski, Grazyna Plucienniczak, Andrzej Plucienniczak


  • Open Access

    Mobilizable narrow host range plasmids as natural suicide vectors enabling horizontal gene transfer among distantly related bacterial species

    by Maria Smorawinska, Magdalena Szuplewska, Piotr Zaleski, Paweł Wawrzyniak, Anna Maj, Andrzej Plucienniczak, Dariusz Bartosik

    Klebsiella pneumoniae 287-w carries three small narrow host range (NHR) plasmids (pIGMS31, pIGMS32, and pIGRK), which could be maintained in several


  • The complete sequence and segregational stability analysis of a new cryptic plasmid pIGWZ12 from a clinical strain of Escherichia coli

    by Piotr Zaleski, Renata Wolinowska, Krystyna Strzezek, Agata Lakomy, Andrzej Plucienniczak


  • Open Access

    The role of Dam methylation in phase variation of Haemophilus influenzae genes involved in defence against phage infection

    by Piotr Zaleski, Marek Wojciechowski, Andrzej Piekarowicz

    Haemophilus influenzae uses phase variation (PV) to modulate the activity of its defence systems against phage infection. The PV of the restriction–modification (R-M) system HindI, the main defence system against phage infection and incoming chromosomal and phage DNA in H. influenzae Rd, is driven by changes of the pentanucleotide repeat tract within the coding sequence of the hsdM gene and is influenced by lack of Dam methylation. Phase-variable resistance/sensitivity to phage infection correlates with changes in lipooligosaccharide (LOS) structure and occurs by slippage of tetranucleotide repeats within the gene lic2A, coding for a step in the biosynthesis of LOS. The lack of Dam activity destabilizes the tetranuclotide (5′-CAAT) repeat tract and increases the frequency of switching from sensitivity to resistance to phage infection more than in the opposite direction. The PV of the lgtC gene does not influence resistance or sensitivity to phage infection. Insertional inactivation of lic2A, but not lgtC or lgtF, leads to resistance to phage infection and to the same structure of the LOS as observed among phase-variable phage-resistant variants. This indicates that in the H. influenzae Rd LOS only the first two sugars (Glc-Gal) extending from the third heptose are part of bacterial phage receptors.